Nachrichten zur Sarepta Therapeutics Inc. Aktie

Sarepta Therapeutics: Another Hold Call Ahead Of Some Key Catalysts

…

Thanks to exchange-traded funds (ETFs), investors don’t have to be tied to one specific stock. Biotech ETFs allow market participants…

The upcoming regulatory decision on its latest drug could be big.…

UBS raises Sarepta Therapeutics shares target on label outlook…

SRPT earnings call for the period ending December 31, 2023.…

…

The companys hyperfocus on its core area could continue to be highly lucrative.…